Knee Osteoarthritis and Stem Cells: A Realistic Look at the Trial Data
Medically reviewed by Dr. Charles Pereyra, MD — Medical Director, Springs Rejuvenation. Last reviewed June 22, 2026.
Written by the Springs Rejuvenation regenerative medicine team from direct clinical experience administering stem cell and exosome protocols at our Aventura, Miami center.
Knee osteoarthritis is wear-and-tear damage to the cartilage that lets your knee glide smoothly. It is one of the most common reasons people explore regenerative medicine, and it is also one of the areas where marketing claims have run far ahead of the science. This article tries to do the opposite: walk through what the better-quality trials actually report so you can make a grounded decision.
What the studies are measuring
Most randomized trials of cell-based therapy for knee osteoarthritis track two things: pain and function over time, usually with validated scoring tools, and sometimes cartilage appearance on MRI. The patients enrolled typically have mild-to-moderate osteoarthritis, because severe bone-on-bone joints behave very differently and tend to respond less.
The honest summary of results
Across several controlled trials, a number of patients have reported meaningful reductions in pain and improvements in day-to-day function that lasted six to twelve months, with some studies reporting longer. A handful of trials have noted modest signals on imaging, but cartilage regeneration in humans remains an area where the evidence is mixed and should not be over-promised. The fairest reading is that stem cell therapy may help symptoms in well-selected patients with earlier-stage disease, while reliably rebuilding a worn-out joint is not something the data supports today.
Why patient selection matters so much
The same therapy can look impressive in one trial and underwhelming in another, and a big reason is who was enrolled. Body weight, activity level, alignment of the leg, and how advanced the osteoarthritis is all change the odds. A good regenerative program spends as much time deciding whether you are a candidate as it does on the injection itself.
Will stem cell therapy supports my arthritis?
No. Osteoarthritis is a chronic, progressive condition, and no injection supports it. The realistic goal is to support the joint, ease symptoms, and potentially delay more invasive steps. Results vary from person to person.
How does it compare to a cortisone shot?
Cortisone can calm inflammation quickly but its benefit often fades and repeated use may not be ideal for the joint. Regenerative approaches aim to support the tissue environment rather than simply suppress inflammation, though they tend to work more gradually.
Am I too far along to be a candidate?
Possibly. Bone-on-bone, severe osteoarthritis is generally a weaker candidate for injections, and a joint-replacement consult may serve you better. We will give you a straight answer after reviewing your imaging.
How we approach it at Springs
We grade your osteoarthritis, look at the whole leg rather than just the knee, and only recommend a regenerative plan when the evidence suggests you have a reasonable chance of benefit. If you are too advanced, we say so. A free consultation is the place to get an honest read on your specific knee.
At Springs Rejuvenation, stem cell and exosome therapies are used together as part of a personalized regenerative protocol.
Medical Disclaimer: Stem cell and exosome therapy is not an FDA approved therapy and is considered to be in the experimental stages. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Springs Rejuvenation processes exosomes in an FDA approved lab. Individual results may vary. This content is reviewed for medical accuracy by Dr. Charles Pereyra, MD, Medical Director of Springs Rejuvenation, and is provided for educational purposes only. Always consult a qualified physician.